Order byBest matchMost fresh

FDA plans to limit COVID vaccine to only high-risk people

Digest more
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
Vaccine manufacturers will need to conduct "randomized, placebo-controlled trials" before the FDA will approve future applications to give shots to "all healthy persons" between the ages of 6 months ...

Continue reading

FDA plans to limit COVID shots to those over 65 or with high-risk conditions
FDA may limit future Covid-19 shots to older people and those at risk of serious infection
New Trump vaccine policy limits access to COVID shots
The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending more data on everyone else — raising questions about whether some p...

Continue reading

FDA panel recommends keeping COVID shots targeted to same strain as last year
FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules
FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?
Public trust in vaccination has declined, potentially impacting other vital immunization programs.

Continue reading

WA vaccine scientists push back against FDA changes around COVID shots
COVID shots should target newer strains of JN.1 variant in 2025-26 campaign, US FDA advisers say
Public Broadcasting Service (PBS)1d
Who is eligible for a COVID shot? What to know about the FDA’s latest changes
The shift was a marked departure from previous FDA guidance, which recommended an annual COVID vaccine for everyone 6 months and older.
STAT2d
New FDA framework on Covid vaccines leaves pediatricians confused and concerned
A new FDA framework for Covid-19 vaccines created confusion among physicians about what it means for young children
mlive9h
COVID-19 booster eligibility may be changing. Michigan’s uptake was already low
Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.
Universal vaccines could reshape how we fight future outbreaks – but a broad approach is needed
Earlier this month, the US government announced a US$500 million (£377 million) investment to accelerate research into universal vaccines. After years of underfunding, experts say this backing is long overdue – especially following the COVID pandemic, which temporarily shifted focus to emergency vaccine production.
What's the future of COVID-19 vaccines in Australia after US restricts access?
The US Food and Drug Administration is changing how it approves COVID-19 vaccines for Americans. What does that mean for people wanting to get vaccinations in Australia?
With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines,
WHO members adopt a ‘pandemic agreement’ born out of the disjointed global COVID response
The World Health Organization's member countries have approved an agreement to better prevent, prepare for and respond to future pandemics in the wake of the devastation wrought by the coronavirus.
Researchers explore COVID-19 vaccine attitudes and motivations, finding common values
Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust make it challenging to craft effective public health responses.
Feedback